Live-attenuated Yersinia pestis vaccines

被引:2
|
作者
Wang, Xiaoyi [1 ]
Zhang, Xuecan [1 ]
Zhou, Dongsheng [1 ]
Yang, Ruifu [1 ]
机构
[1] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
关键词
live-attenuated vaccines; plague; Yersinia pestis; PNEUMONIC PLAGUE; BUBONIC PLAGUE; FUSION PROTEIN; PLASMINOGEN-ACTIVATOR; TRANSFERABLE PLASMID; PROTECTIVE IMMUNITY; PASTEURELLA-PESTIS; TRANS-TRANSLATION; RECEPTOR PROTEIN; SUBUNIT VACCINE;
D O I
10.1586/ERV.13.42
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plague caused by Yersinia pestis is one of the most dangerous infectious diseases. There is no ideal plague vaccine available for human use, but a number of licensed killed whole-cell and live-attenuated vaccines have been available in the past. Currently, there are a number of vaccines under development, including live-attenuated, DNA and subunit vaccines, among others. This review deals with the development of live-attenuated plague vaccines. Traditionally, live-attenuated plague vaccines have been developed by multiple passages of fully virulent Y. pestis, but they have not gained general acceptance due to safety concerns. Recent attempts to construct attenuated Y. pestis strains with specifically defined mutations have opened the door for developing new candidates for live-attenuated plague vaccines, with a proper balance between safety and protective efficacy.
引用
收藏
页码:677 / 686
页数:10
相关论文
共 50 条
  • [1] Rational Considerations about Development of Live Attenuated Yersinia pestis Vaccines
    Sun, Wei
    Curtiss, Roy, III
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2013, 14 (10) : 878 - 886
  • [2] Live-attenuated Shigella vaccines
    Venkatesan, Malabi M.
    Ranallo, Ryan T.
    EXPERT REVIEW OF VACCINES, 2006, 5 (05) : 669 - 686
  • [3] Evolution of Live-Attenuated HIV Vaccines
    Berkhout, Ben
    BIOPHARM INTERNATIONAL, 2011, 24 (01) : S4 - S8
  • [4] Improvements in live-attenuated HIV vaccines?
    不详
    IMMUNOLOGY TODAY, 1996, 17 (09): : 401 - 401
  • [5] Developing live vaccines against Yersinia pestis
    Sun, Wei
    Roland, Kenneth L.
    Curtiss, Roy, III
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2011, 5 (09): : 614 - 627
  • [7] Population dynamics of live-attenuated virus vaccines
    Wagner, Bradley G.
    Earn, David J. D.
    THEORETICAL POPULATION BIOLOGY, 2010, 77 (02) : 79 - 94
  • [8] Live-Attenuated Respiratory Syncytial Virus Vaccines
    Karron, Ruth A.
    Buchholz, Ursula J.
    Collins, Peter L.
    CHALLENGES AND OPPORTUNITIES FOR RESPIRATORY SYNCYTIAL VIRUS VACCINES, 2013, 372 : 259 - 284
  • [9] Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines
    Pena, Lindomar
    Sutton, Troy
    Chockalingam, Ashok
    Kumar, Sachin
    Angel, Matthew
    Shao, Hongxia
    Chen, Hongjun
    Li, Weizhong
    Perez, Daniel R.
    JOURNAL OF VIROLOGY, 2013, 87 (09) : 5118 - 5127
  • [10] Rational Development of Live-Attenuated Zika Virus Vaccines
    Adam, Awadalkareem
    Lee, Christy
    Wang, Tian
    PATHOGENS, 2023, 12 (02):